loadpatents
name:-0.13468289375305
name:-0.059724092483521
name:-0.010177850723267
Kishimoto; Takashi Kei Patent Filings

Kishimoto; Takashi Kei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kishimoto; Takashi Kei.The latest application filed is for "methods and compositions for reducing immune responses against immunoglobulin proteases".

Company Profile
8.33.86
  • Kishimoto; Takashi Kei - Lexington MA
  • Kishimoto, Takashi Kei - New Fairfield CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Reducing Immune Responses Against Immunoglobulin Proteases
App 20220133864 - Kishimoto; Takashi Kei
2022-05-05
Methods Of Administering Immunosuppressants Having A Specified Pharmacodynamic Effective Life And Therapeutic Macromolecules For The Induction Of Immune Tolerance
App 20220071968 - Kishimoto; Takashi Kei
2022-03-10
Methods And Compositions Using Synthetic Nanocarriers Comprising Immunosuppressant
App 20210290601 - Ilyinskii; Petr ;   et al.
2021-09-23
Formulations And Doses Of Pegylated Uricase
App 20210187081 - Johnston; Lloyd ;   et al.
2021-06-24
Methods And Compositions For Treating Liver Diseases And Disorders
App 20210154324 - Ilyinskii; Petr ;   et al.
2021-05-27
Formulations And Doses Of Pegylated Uricase
App 20200399628 - Johnston; Lloyd ;   et al.
2020-12-24
Methods And Compositions For Attenuated Anti-viral Transfer Vector Immune Response
App 20200390718 - Kishimoto; Takashi Kei ;   et al.
2020-12-17
Methods For Treatment Of Subjects With Preexisting Immunity To Viral Transfer Vectors
App 20200360453 - Kishimoto; Takashi Kei ;   et al.
2020-11-19
Methods Related To Administering Immunosuppressants And Therapeutic Macromolecules At A Reduced Pharmacodynamically Effective Do
App 20200113874 - Maldonado; Roberto A. ;   et al.
2020-04-16
Tolerogenic Synthetic Nanocarriers For Generating Cd8+ Regulatory T Cells
App 20200101155 - Kishimoto; Takashi Kei ;   et al.
2020-04-02
Tolerogenic Synthetic Nanocarriers For Antigen-specific Deletion Of T Effector Cells
App 20200101154 - Fraser; Christopher ;   et al.
2020-04-02
Methods Comprising Dosing Combinations For Reducing Undesired Humoral Immune Responses
App 20200069660 - Maldonado; Roberto A. ;   et al.
2020-03-05
Methods Of Administering Immunosuppressants Having A Specified Pharmacodynamic Effective Life And Therapeutic Macromolecules For
App 20200069659 - Kishimoto; Takashi Kei
2020-03-05
Methods And Compositions Of Mma Constructs And Vectors
App 20200038463 - Keller; Peter ;   et al.
2020-02-06
Methods And Compositions Of Otc Constructs And Vectors
App 20200038462 - Keller; Peter ;   et al.
2020-02-06
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
Grant 10,441,651 - Kishimoto , et al. Oc
2019-10-15
Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
Grant 10,434,088 - Maldonado , et al. O
2019-10-08
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
Grant 10,420,835 - Fraser , et al. Sept
2019-09-24
Methods comprising dosing combinations for reducing undesired humoral immune responses
Grant 10,357,483 - Maldonado , et al. July 23, 2
2019-07-23
Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance
Grant 10,335,395 - Kishimoto
2019-07-02
Methods And Compositions For Attenuating Anti-viral Transfer Vector Igm Responses
App 20190142974 - Ilyinskii; Petr ;   et al.
2019-05-16
Methods And Compositions For Attenuating Gene Expression Modulating Anti-viral Transfer Vector Immune Responses
App 20190076458 - Kishimoto; Takashi Kei
2019-03-14
Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
Grant 10,071,114 - Kishimoto September 11, 2
2018-09-11
Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
Grant 10,046,064 - Kishimoto August 14, 2
2018-08-14
Patterned Dosing Of Immunosuppressants Coupled To Synthetic Nanocarriers
App 20180193482 - Ilyinskii; Petr ;   et al.
2018-07-12
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
Grant 10,004,802 - Kishimoto , et al. June 26, 2
2018-06-26
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
Grant 9,987,354 - Fraser , et al. June 5, 2
2018-06-05
Methods And Compositions For Treating Cancer
App 20180085319 - Kishimoto; Takashi Kei
2018-03-29
Tolerogenic Synthetic Nanocarriers For Allergy Therapy
App 20160279234 - KISHIMOTO; TAKASHI KEI ;   et al.
2016-09-29
Tolerogenic Synthetic Nanocarriers To Reduce Immune Responses To Therapeutic Proteins
App 20160256401 - Fraser; Christopher ;   et al.
2016-09-08
Polysaccharide Compositions And Methods Of Use For The Treatment And Prevention Of Disorders Associated With Progenitor Cell Mobilization
App 20160243153 - Sundaram; Mallikarjun ;   et al.
2016-08-25
Tolerogenic Synthetic Nanocarriers To Reduce Immune Responses To Therapeutic Proteins
App 20160220501 - Fraser; Christopher ;   et al.
2016-08-04
Tissue targeting
Grant 9,387,256 - Zhou , et al. July 12, 2
2016-07-12
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
Grant 9,358,252 - Sundaram , et al. June 7, 2
2016-06-07
Non-anticoagulant polysaccharide compositions
Grant 9,351,992 - Sundaram , et al. May 31, 2
2016-05-31
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
Grant 9,295,718 - Fraser , et al. March 29, 2
2016-03-29
Tolerogenic synthetic nanocarriers for allergy therapy
Grant 9,289,476 - Kishimoto , et al. March 22, 2
2016-03-22
Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
Grant 9,289,477 - Fraser , et al. March 22, 2
2016-03-22
Methods And Compositions For Attenuating Gene Expression Modulating Anti-viral Transfer Vector Immune Responses
App 20160074427 - Kishimoto; Takashi Kei
2016-03-17
Methods And Compositions For Attenuating Gene Therapy Anti-viral Transfer Vector Immune Responses
App 20160074531 - Kishimoto; Takashi Kei
2016-03-17
Methods And Compositions For Attenuating Gene Editing Anti-viral Transfer Vector Immune Responses
App 20160074532 - Kishimoto; Takashi Kei
2016-03-17
Methods And Compositions For Attenuating Exon Skipping Anti-viral Transfer Vector Immune Responses
App 20160074372 - Kishimoto; Takashi Kei
2016-03-17
Methods And Compositions For Attenuating Anti-viral Transfer Vector Immune Responses
App 20160067228 - Kishimoto; Takashi Kei
2016-03-10
Polysaccharide Compositions And Methods Of Use For The Treatment And Prevention Of Disorders Associated With Progenitor Cell Mobilization
App 20160060366 - Sundaram; Mallikarjun ;   et al.
2016-03-03
Tolerogenic Synthetic Nanocarriers For Allergy Therapy
App 20160030554 - Kishimoto; Takashi Kei ;   et al.
2016-02-04
Tolerogenic Synthetic Nanocarriers For Generating Cd8+ Regulatory T Cells
App 20160030555 - Kishimoto; Takashi Kei ;   et al.
2016-02-04
Tolerogenic Synthetic Nanocarriers To Reduce Cytotoxic T Lymphocyte Responses
App 20160022650 - Fraser; Christopher ;   et al.
2016-01-28
Methods And Compositions For Treatment With Synthetic Nanocarriers And Immune Checkpoint Inhibitors
App 20150374815 - Kishimoto; Takashi Kei ;   et al.
2015-12-31
Tolerogenic Synthetic Nanocarriers For T-cell-mediated Autoimmune Disease
App 20150359865 - Kishimoto; Takashi Kei
2015-12-17
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
Grant 9,212,233 - Sundaram , et al. December 15, 2
2015-12-15
Tolerogenic Synthetic Nanocarriers To Reduce Immune Responses To Therapeutic Proteins
App 20150335762 - Fraser; Christopher ;   et al.
2015-11-26
Tolerogenic Synthetic Nanocarriers For Antigen-specific Deletion Of T Effector Cells
App 20150320884 - Fraser; Christopher ;   et al.
2015-11-12
Tolerogenic Synthetic Nanocarriers To Reduce Antibody Responses
App 20150320728 - Fraser; Christopher ;   et al.
2015-11-12
Saccharide structures and methods of making and using such structures
Grant 9,163,047 - Roy , et al. October 20, 2
2015-10-20
Repeated Administration Of Non-immunosuppressive Antigen Specific Immunotherapeutics
App 20140356361 - Maldonado; Roberto A. ;   et al.
2014-12-04
Methods And Compositions For Enhancing Cd4+ Regulatory T Cells
App 20140335186 - Kishimoto; Takashi Kei ;   et al.
2014-11-13
Tolerogenic Synthetic Nanocarriers And Therapeutic Macromolecules For Reduced Or Enhanced Pharmacodynamic Effects
App 20140328854 - Maldonado; Roberto A. ;   et al.
2014-11-06
Dosing Combinations For Reducing Undesired Humoral Immune Responses
App 20140328923 - Maldonado; Roberto A. ;   et al.
2014-11-06
Delivery Of Immunosuppressants Having A Specified Pharmacodynamic Effective-life And Antigen For The Induction Of Immune Tolerance
App 20140328924 - Kishimoto; Takashi Kei
2014-11-06
Copolymer assay
Grant 8,753,833 - D'Alessandro , et al. June 17, 2
2014-06-17
Polysaccharide Compositions And Methods Of Use For The Treatment And Prevention Of Disorders Associated With Progenitor Cell Mobilization
App 20140031315 - Sundaram; Mallikarjun ;   et al.
2014-01-30
Polysaccharide Compositions And Methods Of Use For The Treatment And Prevention Of Disorders Associated With Progenitor Cell Mobilization
App 20140024602 - Sundaram; Mallikarjun ;   et al.
2014-01-23
Saccharide structures and methods of making and using such structures
Grant 8,614,314 - Sucharita , et al. December 24, 2
2013-12-24
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
Grant 8,592,393 - Sundaram , et al. November 26, 2
2013-11-26
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
Grant 8,569,262 - Sundaram , et al. October 29, 2
2013-10-29
Tissue Targeting
App 20130156698 - Zhou; He ;   et al.
2013-06-20
Transplantable Graft-specific Induced Tolerogenic Dendritic Cells And Methods Of Use
App 20130058901 - Maldonado; Roberto A. ;   et al.
2013-03-07
Allergen-specific Induced Tolerogenic Dendritic Cells For Allergy Therapy
App 20130058976 - Kishimoto; Takashi Kei ;   et al.
2013-03-07
Induced Tolerogenic Dendritic Cells To Reduce Systemic Inflammatory Cytokines
App 20130058970 - Kishimoto; Takashi Kei ;   et al.
2013-03-07
Antigen-specific Induced Tolerogenic Dendritic Cells To Reduce Cytotoxic T Lymphocyte Responses
App 20130058974 - Maldonado; Roberto A. ;   et al.
2013-03-07
Induced Tolerogenic Dendritic Cells For Generating Cd8+ Regulatory T Cells
App 20130058963 - Maldonado; Roberto A. ;   et al.
2013-03-07
Compositions And Methods For Producing Antigen-specific Induced Tolerogenic Dendritic Cells With Synthetic Nanocarriers
App 20130059009 - Kishimoto; Takashi Kei ;   et al.
2013-03-07
Antigen-specific Induced Tolerogenic Dendritic Cells To Reduce Antibody Responses
App 20130058975 - Maldonado; Roberto A. ;   et al.
2013-03-07
Therapeutic Protein-specific Induced Tolerogenic Dendritic Cells And Methods Of Use
App 20130058894 - Maldonado; Roberto A. ;   et al.
2013-03-07
Dendritic Cell Subsets For Generating Induced Tolerogenic Dendritic Cells And Related Compositions And Methods
App 20130058902 - Kishimoto; Takashi Kei ;   et al.
2013-03-07
Compositions And Methods Related To Induced Tolerogenic Dendritic Cells Externally Loaded With Mhc Class I-restricted Epitopes
App 20130058977 - Maldonado; Roberto A. ;   et al.
2013-03-07
Tolerogenic Synthetic Nanocarriers Coupled To Cd1d-restricted Antigens And Methods Of Use
App 20120301510 - Kishimoto; Takashi Kei ;   et al.
2012-11-29
Tolerogenic Synthetic Nanocarriers For Allergy Therapy
App 20120294888 - Kishimoto; Takashi Kei ;   et al.
2012-11-22
Tolerogenic Synthetic Nanocarriers To Reduce Antibody Responses
App 20120276157 - Fraser; Christopher ;   et al.
2012-11-01
Tolerogenic Synthetic Nanocarriers For Antigen-specific Deletion Of T Effector Cells
App 20120276134 - Fraser; Christopher ;   et al.
2012-11-01
Tolerogenic Synthetic Nanocarriers To Reduce Immune Responses To Therapeutic Proteins
App 20120276109 - Fraser; Christopher ;   et al.
2012-11-01
Tolerogenic Synthetic Nanocarriers For Generating Cd8+ Regulatory T Cells
App 20120276155 - Kishimoto; Takashi Kei ;   et al.
2012-11-01
Tolerogenic Synthetic Nanocarriers To Reduce Cytotoxic T Lymphocyte Responses
App 20120276158 - Fraser; Christopher ;   et al.
2012-11-01
Tolerogenic Synthetic Nanocarrier Compositions With Transplantable Graft Antigens And Methods Of Use
App 20120276156 - Fraser; Christopher ;   et al.
2012-11-01
Methods Of Assessing Activity Of A Polysaccharide Composition
App 20120183976 - Zhou; He ;   et al.
2012-07-19
Saccharide Structures And Methods Of Making And Using Such Structures
App 20110201801 - Roy; Sucharita ;   et al.
2011-08-18
Copolymer Assay
App 20110053203 - D'Alessandro; Josephine S. ;   et al.
2011-03-03
Polysaccharide Compositions And Methods Of Use For The Treatment And Prevention Of Disorders Associated With Progenitor Cell Mobilization
App 20100324276 - SUNDARAM; Mallikarjun ;   et al.
2010-12-23
Polysaccharide Compositions And Methods Of Use For The Treatment And Prevention Of Disorders Associated With Progenitor Cell Mobilization
App 20100316640 - SUNDARAM; Mallikarjun ;   et al.
2010-12-16
Non-anticoagulant Polysaccharide Compositions
App 20100298260 - Sundaram; Mallikarjun ;   et al.
2010-11-25
Modulation of L-selectin shedding via inhibition of tumor necrosis factor-.alpha. converting enzyme (TACE)
Grant 6,632,667 - Bennett , et al. October 14, 2
2003-10-14
Antisense modulation of cytohesin-1 expression
App 20020147164 - Bennett, C. Frank ;   et al.
2002-10-10
Antisense modulation of Talin expression
App 20020147166 - Bennett, C. Frank ;   et al.
2002-10-10
Antisense modulation of calreticulin expression
App 20020147165 - Bennett, C. Frank ;   et al.
2002-10-10
Company Registrations
SEC0001676930Kishimoto Takashi Kei

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed